Table 4.
AUC/△AUC | 95% CI | P value | |
---|---|---|---|
CV death and TVMI | |||
AUC combined | 0.682 | 0.609–0.755 | – |
AUC SHR | 0.659 | 0.582–0.737 | – |
AUC TyG | 0.623 | 0.582–0.698 | – |
AUC combined–AUC TyG | 0.058 | − 0.006–0.121 | 0.074 |
AUC combined–AUC SHR | 0.022 | − 0.015–0.060 | 0.247 |
AUC SHR– AUC TyG | 0.036 | − 0.057–0.128 | 0.452 |
MACCEs | |||
AUC combined | 0.633 | 0.589–0.676 | – |
AUC SHR | 0.624 | 0.580–0.668 | – |
AUC TyG | 0.589 | 0.546–0.633 | – |
AUC combined–AUC TyG | 0.043 | 0.009–0.077 | 0.014 |
AUC combined–AUC SHR | 0.009 | − 0.013–0.030 | 0.426 |
AUC SHR– AUC TyG | 0.034 | − 0.084–0.016 | 0.179 |
Optimal cut-off: (1) the composite of CV death and TVMI: TyG, 8.98; SHR: 0.86; (2) MACCE: TyG, 9.07; SHR: 0.88
TyG triglyceride-glucose, CV cardiovascular, TVMI target vessel myocardial infarction, MACCEs major adverse CV cerebral events, SHR stress-hyperglycemia ratio